Literature DB >> 3548792

Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit.

P M Yate, P J Flynn, R W Arnold, B C Weatherly, R J Simmonds, T Dopson.   

Abstract

Twenty patients in the intensive care unit received an infusion of atracurium to permit mechanical ventilation. The duration of infusion ranged from 38 to 219 h and the average rate of infusion during the study was 0.76 mg kg-1 h-1. In 14 patients an increase in atracurium requirement occurred within the first 72 h of the infusion. Recovery from neuromuscular blockade after a prolonged infusion was sufficiently rapid to avoid pharmacologically induced reversal. In six patients maximum plasma concentrations of laudanosine were 1.9-5 micrograms ml-1, and there was no evidence of cerebral excitation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548792     DOI: 10.1093/bja/59.2.211

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  11 in total

1.  Residual curarization in the neonate after caesarean section.

Authors:  C Perreault; J Guay; P Gaudreault; L Cyrenne; F Varin
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

3.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

Review 4.  Atracurium and laudanosine pharmacokinetics in acute renal failure.

Authors:  J M Hunter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 5.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

6.  Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.

Authors:  J F Bion; M I Bowden; B Chow; L Honisberger; B C Weatherley
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  The use of neuromuscular blocking drugs in the intensive care unit: a US perspective.

Authors:  M J Murray; R A Strickland; C Weiler
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.

Authors:  A J Pearson; N J Harper; B J Pollard
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 9.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

Review 10.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.